Skip Navigation



JAC Advance Access published online on February 28, 2006
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkl017
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
57/4/589    most recent
dkl017v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gemmell, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gemmell, C. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Review

Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK

Curtis G. Gemmell 1, David I. Edwards 2, Adam P. Fraise 3, F. Kate Gould 4, Geoff L. Ridgway 5, Rod E. Warren 6 *, and on behalf of the Joint Working Party of the British Society for Antimicrobial Chemotherapy, Hospital Infection Society and Infection Control Nurses Association

1 Department of Bacteriology, Royal Infirmary, 84-86 Castle Street, Glasgow G4 0SF, Scotland, UK
2 39 Wallenger Avenue, Gidea Park, Romford, London RM2 6EP, UK
3 Department of Medical Microbiology, City Hospital NHS Trust, Dudley Road, Birmingham B18 7QH, UK
4 Department of Microbiology, Freeman Hospital, Freeman Road, High Heaton, Newcastle-upon-Tyne NE7 7DN, UK
5 Department of Health, Wellington House, 133-155 Waterloo Road, London SE1, UK
6 Department of Microbiology, Royal Shrewsbury Hospital, Mytton Oak Road, Shrewsbury SY3 8XQ, UK

* To whom correspondence should be addressed.
Rod E. Warren, E-mail: rod.warren{at}rsh.nhs.uk


  Abstract

These evidence-based guidelines have been produced after a literature review of the treatment and prophylaxis of methicillin-resistant Staphylococcus aureus (MRSA) infection. The guidelines were further informed by antibiotic susceptibility data on MRSA from the UK. Recommendations are given for the treatment of common infections caused by MRSA, elimination of MRSA from carriage sites and prophylaxis of surgical site infection. There are several antibiotics currently available that are suitable for use in the management of this problem and potentially useful new agents are continuing to emerge.

Keywords: methicillin; MRSA guidelines; evidence-based guidelines; meticillin.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
R. Brindle and on behalf of Wessex Microbiologists
Has the publication of methicillin-resistant Staphylococcus aureus (MRSA) treatment guidelines increased the survival associated with MRSA bacteraemia?
J. Antimicrob. Chemother., November 1, 2009; 64(5): 1111 - 1113.
[Abstract] [Full Text] [PDF]

Home page
 Contin Educ Anaesth Crit Care PainHome page
A.J. Varley, H. Williams, and S. Fletcher
Antibiotic resistance in the intensive care unit
CEACCP, August 1, 2009; 9(4): 114 - 118.
[Full Text] [PDF]

Home page
 CJASNHome page
S. J. Vandecasteele, J. R. Boelaert, and A. S. De Vriese
Staphylococcus aureus Infections in Hemodialysis: What a Nephrologist Should Know
Clin. J. Am. Soc. Nephrol., August 1, 2009; 4(8): 1388 - 1400.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
F. K. Gould, R. Brindle, P. R. Chadwick, A. P. Fraise, S. Hill, D. Nathwani, G. L. Ridgway, M. J. Spry, R. E. Warren, and on behalf of the MRSA Working Party of the British
Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom
J. Antimicrob. Chemother., May 1, 2009; 63(5): 849 - 861.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
A. H. Thomson, C. E. Staatz, C. M. Tobin, M. Gall, and A. M. Lovering
Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations
J. Antimicrob. Chemother., May 1, 2009; 63(5): 1050 - 1057.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
J. Kluytmans and M. Struelens
Meticillin resistant Staphylococcus aureus in the hospital
BMJ, February 12, 2009; 338(feb12_1): b364 - b364.
[Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
K. E. Bowker, A. R. Noel, and A. P. MacGowan
Pharmacodynamics of Minocycline against Staphylococcus aureus in an In Vitro Pharmacokinetic Model
Antimicrob. Agents Chemother., December 1, 2008; 52(12): 4370 - 4373.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
X. Malaviolle, C. Nonhoff, O. Denis, S. Rottiers, and M. J. Struelens
Evaluation of disc diffusion methods and Vitek 2 automated system for testing susceptibility to mupirocin in Staphylococcus aureus
J. Antimicrob. Chemother., November 1, 2008; 62(5): 1018 - 1023.
[Abstract] [Full Text] [PDF]

Home page
 J Bone Joint Surg BrHome page
A. Patel, R. P. Calfee, M. Plante, S. A. Fischer, N. Arcand, and C. Born
Methicillin-resistant Staphylococcus aureus in orthopaedic surgery
J Bone Joint Surg Br, November 1, 2008; 90-B(11): 1401 - 1406.
[Abstract] [Full Text] [PDF]

Home page
 J Bone Joint Surg BrHome page
D. S. NEOGI, C. S. YADAV, and S. RASTOGI
Surgical site infection with methicillin-resistant Staphylococcus aureus after primary total hip replacement
J Bone Joint Surg Br, November 1, 2008; 90-B(11): 1536 - 1536.
[Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. A. Seaton
Daptomycin: rationale and role in the management of skin and soft tissue infections
J. Antimicrob. Chemother., November 1, 2008; 62(suppl_3): iii15 - iii23.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. G. Masterton, A. Galloway, G. French, M. Street, J. Armstrong, E. Brown, J. Cleverley, P. Dilworth, C. Fry, A. D. Gascoigne, et al.
Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy
J. Antimicrob. Chemother., July 1, 2008; 62(1): 5 - 34.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
K. O. Helgason, A. H. Thomson, and C. Ferguson
A review of vancomycin therapeutic drug monitoring recommendations in Scotland
J. Antimicrob. Chemother., June 1, 2008; 61(6): 1398 - 1399.
[Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
D. Nathwani, M. Morgan, R. G. Masterton, M. Dryden, B. D. Cookson, G. French, D. Lewis, and on behalf of the British Society for Antimicrobial
Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community
J. Antimicrob. Chemother., May 1, 2008; 61(5): 976 - 994.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
R. A. Herman, V. R. Kee, K. G. Moores, and M. B. Ross
Etiology and treatment of community-associated methicillin-resistant Staphylococcus aureus
Am. J. Health Syst. Pharm., February 1, 2008; 65(3): 219 - 225.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
K. O. Helgason, M. E. Jones, and G. Edwards
Panton-Valentine Leukocidin-Positive Staphylococcus aureus and Foreign Travel
J. Clin. Microbiol., February 1, 2008; 46(2): 832 - 833.
[Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
E. Tacconelli, G. De Angelis, M. A. Cataldo, E. Pozzi, and R. Cauda
Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis
J. Antimicrob. Chemother., January 1, 2008; 61(1): 26 - 38.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
I. Chopra
The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern?
J. Antimicrob. Chemother., April 1, 2007; 59(4): 587 - 590.
[Abstract] [Full Text] [PDF]

Home page
 DTBHome page
Treating impetigo in primary care
DTB, January 1, 2007; 45(1): 2 - 4.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
G. L. French
Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin
J. Antimicrob. Chemother., December 1, 2006; 58(6): 1107 - 1117.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
L. Leibovici and M. Paul
Comment on Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK
J. Antimicrob. Chemother., July 1, 2006; 58(1): 220 - 220.
[Full Text] [PDF]

Home page
 BMJHome page
J. Greig and P. Jenks
More on pneumonia: treatment of MRSA in community acquired pneumonia.
BMJ, June 3, 2006; 332(7553): 1334 - 1334.
[Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.